.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B03A_IronPreparations.B03AB01_FerricSodiumCitrate.FerricSodiumCitrate .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B03A_IronPreparations.B03AB01_FerricSodiumCitrate.FerricSodiumCitrate| name: | FerricSodiumCitrate |
| ATC code: | B03AB01 | route: | oral |
| n-compartments | 1 |
Ferric sodium citrate is an iron salt used primarily as an oral phosphate binder in the management of hyperphosphatemia, particularly in patients with chronic kidney disease on dialysis. It provides a source of iron for absorption and aids in reducing phosphate absorption from the gut. Ferric sodium citrate is approved and used therapeutically, especially in Japan.
There are no published studies that provide detailed compartmental pharmacokinetic parameters for ferric sodium citrate in humans. The values below are estimated for an adult population receiving a typical oral dose for phosphate binding.